Home>Topics>Stocks>Warner Chilcott Limited A

Warner Chilcott Limited A

  1. All
  2. Commentary
  3. Headlines
  1. Actavis Meets Expectations Despite Goodwill Charge

    Commentary

    Thu, 25 Jul 2013

    launches. We're still a bit concerned about long-term growth prospects in the branded segment, including Warner Chilcott's WCRX existing portfolio, but we imagine management will seek additional deals in complex generics and branded pharmaceuticals over

  2. Actavis and Warner Chilcott Announce All-Stock Deal

    Commentary

    Mon, 20 May 2013

    Actavis ACT will acquire Warner Chilcott WCRX in an all-stock deal valued at nearly $8.5 billion. We're placing both companies under review as we analyze the combination

  3. Actavis Confirms a Potential Deal With Warner

    Commentary

    Fri, 10 May 2013

    Actavis ACT announced that it has held early stage discussions for a combination with Warner Chilcott WCRX . Actavis has expressed an interest in bolstering its branded specialty pharmaceutical division and pipeline, so the news of a

  4. Warner Chilcott Earnings Benefit From Cost Reductions, but Long-Term Challenges Remain

    Commentary

    Fri, 10 May 2013

    Warner Chilcott WCRX reported first-quarter results that were in line with our expectations. Our thesis remains intact, and we believe our negative

  5. Warner Chilcott Posts Solid 4Q, but Outlook Appears Challenging

    Commentary

    Fri, 22 Feb 2013

    Warner Chilcott WCRX released fourth-quarter earnings that slightly beat our expectations, but the firm had previously released its 2013 financial

  6. Warner Chilcott's 2013 Guidance Misses Expectations, Shares Still Overvalued

    Commentary

    Fri, 8 Feb 2013

    Warner Chilcott WCRX released 2013 guidance that came in below our expectations and the consensus estimates. We continue to believe that shares are

  7. Placing Warner Chilcott Under Review Over Concerns About Long-Term Prospects

    Commentary

    Fri, 9 Nov 2012

    Warner Chilcott WCRX reported solid third-quarter results that were largely in line with expectations. Sales were down 7% due to continued declines

  8. Warner's Secondary Offering Is Disappointing, but Hopefully Will Reduce Private Equity's Control

    Commentary

    Thu, 6 Sep 2012

    Warner Chilcott WCRX announced that major shareholders are selling 43 million shares in a secondary offering. The firm's three largest shareholders

  9. Warner Fails to Find a Buyer, Special Dividend Won't Help the Issues Weighing on its Stock

    Commentary

    Wed, 8 Aug 2012

    Warner Chilcott WCRX announced the completion of its strategic review. The board did not find a suitable acquisition offer, but it plans to pay a

  10. Warner Chilcott Earnings Beat Expectations on Cost Cutting

    Commentary

    Fri, 3 Aug 2012

    Warner Chilcott WCRX posted strong second-quarter results that beat our estimates on both the top and bottom line. The firm maintained its full

« Prev123Next »
Content Partners